Nerve Detective Work: Tests Uncovering Hidden Neuropathy Causes
Peripheral neuropathy affects 20 million Americans, yet half never discover the underlying cause, missing potentially treatable conditions. Comprehensive diagnostic testing can identify over 100 different causes from diabetes to rare genetic disorders, enabling targeted treatment rather than just symptom management. Understanding the full spectrum of neuropathy testing ensures accurate diagnosis and appropriate intervention.
Electrodiagnostic Studies
Nerve conduction studies measure electrical signal speed and strength through nerves. Slowed conduction indicates demyelination while reduced amplitude suggests axonal damage. Patterns distinguish between different neuropathy types guiding treatment approaches.
Electromyography examines muscle electrical activity revealing denervation patterns. Needle insertion might be uncomfortable but provides crucial information about motor nerve involvement. Fibrillation potentials indicate active denervation requiring urgent evaluation.
Small fiber testing using quantitative sensory testing or sudomotor assessment detects neuropathy that standard studies miss. These specialized tests identify pure small fiber neuropathy causing pain without weakness. Early detection enables intervention before progression.
Blood Testing Panels
Comprehensive metabolic panels identify diabetes, kidney disease, or liver dysfunction causing neuropathy. Hemoglobin A1c reveals undiagnosed diabetes in 30% of idiopathic neuropathy. Thyroid function tests detect both hyper and hypothyroidism affecting nerves.
Vitamin deficiency screening especially B12, B1, B6, E, and copper identifies reversible causes. B12 deficiency occurs despite normal serum levels; methylmalonic acid testing improves detection. Excessive B6 from supplements paradoxically causes neuropathy.
Inflammatory markers including ESR, CRP, and autoimmune panels reveal systemic conditions. Antinuclear antibodies, rheumatoid factor, and specific antibodies like anti-SSA suggest connective tissue diseases. Early treatment prevents progression.
Specialized Antibody Testing
Paraneoplastic antibody panels detect cancer-associated neuropathy before tumors appear. Anti-Hu, anti-CV2, and others indicate specific cancer types. Finding these antibodies triggers intensive cancer screening potentially enabling early treatment.
Ganglioside antibodies indicate immune-mediated neuropathies like Guillain-Barré syndrome variants. Different antibody patterns predict clinical course and treatment response. Some variants respond better to plasma exchange versus IVIG.
Anti-MAG antibodies cause specific demyelinating neuropathy requiring different treatment than standard approaches. Rituximab might help when conventional therapy fails. Testing guides therapeutic decisions.
Genetic Testing
Hereditary neuropathy panels test multiple genes simultaneously. Charcot-Marie-Tooth disease has over 90 genetic causes. Identifying specific mutations enables family counseling and determines prognosis.
Transthyretin gene testing for familial amyloidosis is crucial as new treatments exist. Gene silencing therapies and stabilizers can halt progression if started early. Family screening identifies at-risk relatives.
Fabry disease genetic testing reveals this treatable cause of painful neuropathy. Enzyme replacement therapy prevents progression. Often misdiagnosed for years before appropriate testing.
Tissue Biopsies
Skin biopsy measuring epidermal nerve fiber density diagnoses small fiber neuropathy. Simple 3mm punch biopsy with specialized staining quantifies nerve loss. Useful when other tests are normal despite symptoms.
Nerve biopsy reserved for suspected vasculitis or amyloidosis provides definitive diagnosis. Sural nerve biopsy causes permanent numbness but might be necessary for diagnosis. Should be performed at specialized centers.
Lip biopsy for Sjögren’s syndrome reveals salivary gland inflammation. This common cause of neuropathy is often missed without biopsy. Simple office procedure with minimal discomfort.
Imaging Studies
MRI neurography visualizes peripheral nerves identifying compression, tumors, or inflammation. High-resolution imaging shows nerve enlargement in hereditary neuropathies. Guides surgical planning for entrapments.
Ultrasound increasingly used for nerve evaluation. Shows nerve enlargement, compression at entrapment sites, and structural abnormalities. Real-time imaging during movement reveals dynamic compression.
PET scans detect occult malignancies in paraneoplastic neuropathy. Whole-body imaging finds tumors standard screening misses. Essential when antibody testing suggests cancer.
Infectious Disease Screening
HIV, hepatitis B and C testing identifies viral causes requiring specific treatment. Neuropathy might be first manifestation of infection. Early treatment prevents progression and transmission.
Lyme disease testing including Western blot for equivocal ELISA results. Chronic Lyme remains controversial but documented infection requires treatment. Some respond to prolonged antibiotics.
Leprosy testing in endemic areas or immigrants from affected regions. Still causes neuropathy worldwide. Treatable if caught early before permanent damage.
Heavy Metal Testing
Lead, mercury, arsenic, and thallium levels identify toxic neuropathy. Occupational exposure, contaminated supplements, or intentional poisoning are sources. Chelation might reverse early damage.
24-hour urine collection more accurate than blood for some metals. Provocative testing with chelators controversial but sometimes revealing. Hair analysis unreliable except for arsenic.
Environmental exposure assessment crucial for identifying sources. Home testing for lead paint, water analysis, and occupational history guide testing.
Autonomic Testing
Quantitative sudomotor axon reflex testing measures sweating indicating small fiber function. Reduced sweating correlates with neuropathy severity. Useful for monitoring progression.
Heart rate variability testing reveals autonomic neuropathy affecting cardiovascular system. Important for diabetes management. Predicts sudden cardiac death risk.
Tilt table testing identifies orthostatic intolerance from autonomic neuropathy. Guides treatment with medications, salt, and compression garments.
Next Step
Document all neuropathy symptoms including onset, pattern, and progression. List all medications and supplements as some cause neuropathy. Request comprehensive evaluation from neurologist specializing in peripheral nerve disorders. Insist on thorough testing before accepting ‘idiopathic’ diagnosis. Many causes are treatable if identified early. Keep pursuing answers – finding the cause enables targeted treatment potentially halting or reversing neuropathy.
